These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 8738454)
21. Fatal colchicine toxicity. Kubler PA Med J Aust; 2000 May; 172(10):498-9. PubMed ID: 10901774 [No Abstract] [Full Text] [Related]
22. Clinical risk factors for adverse events in allopurinol users. Ryu HJ; Song R; Kim HW; Kim JH; Lee EY; Lee YJ; Song YW; Lee EB J Clin Pharmacol; 2013 Feb; 53(2):211-6. PubMed ID: 23436266 [TBL] [Abstract][Full Text] [Related]
23. Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity. Gillott TJ; Whallett A; Zaphiropoulos G Rheumatology (Oxford); 1999 Jan; 38(1):85-6. PubMed ID: 10334688 [No Abstract] [Full Text] [Related]
25. Colchicine: time to rethink. Varughese GI; Varghese AI; Tahrani AA N Z Med J; 2007 Feb; 120(1249):U2429. PubMed ID: 17308565 [No Abstract] [Full Text] [Related]
26. Treatment failure gout: failure to treat? Perry ME; Madhok R Rheumatology (Oxford); 2010 Dec; 49(12):2233-4. PubMed ID: 20463191 [No Abstract] [Full Text] [Related]
27. Allopurinol: a necessary evil. Lim AY; Teng GG Singapore Med J; 2009 Sep; 50(9):925-6; author reply 927. PubMed ID: 19787189 [No Abstract] [Full Text] [Related]
28. [Hyperuricemia and gout--treatment]. Gröbner W; Walter-Sack I Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994 [No Abstract] [Full Text] [Related]
29. Cardiovascular safety risks associated with gout treatments. Rosas G; Gaffo A; Rahn EJ; Saag KG Expert Opin Drug Saf; 2020 Sep; 19(9):1143-1154. PubMed ID: 32731769 [TBL] [Abstract][Full Text] [Related]
30. A case of multi-organ failure. Tahrani AA; Sharma S; Macleod A; Moulik P Int J Clin Pract; 2007 Mar; 61(3):514-6. PubMed ID: 17313622 [No Abstract] [Full Text] [Related]
31. Colchicine in acute gout. Morgan L Aust Fam Physician; 2008 Mar; 37(3):103; author reply 103. PubMed ID: 18376515 [No Abstract] [Full Text] [Related]
32. [Fatal liver necrosis due to allopurinol]. Pereira S; Almeida J; Silva AO; Quintas M; Candeias O; Freitas F Acta Med Port; 1998 Dec; 11(12):1141-4. PubMed ID: 10192993 [TBL] [Abstract][Full Text] [Related]
33. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events. Dalbeth N; Stamp L Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242 [TBL] [Abstract][Full Text] [Related]
34. Gout: what a pain in the neck. Federman DG; Kravetz JD; Luciano RL; Brown JE Conn Med; 2012 Mar; 76(3):143-6. PubMed ID: 22666972 [No Abstract] [Full Text] [Related]
35. Allopurinol-induced DRESS syndrome in an adolescent patient. Dewan AK; Quinonez RA Pediatr Dermatol; 2010; 27(3):270-3. PubMed ID: 19804493 [TBL] [Abstract][Full Text] [Related]
36. Colchicine use in cyclosporine treated transplant recipients: how little is too much? Simkin PA; Gardner GC J Rheumatol; 2000 Jun; 27(6):1334-7. PubMed ID: 10852250 [No Abstract] [Full Text] [Related]
37. Colchicine myoneuropathy in a renal transplant patient. Dupont P; Hunt I; Goldberg L; Warrens A Transpl Int; 2002 Jul; 15(7):374-6. PubMed ID: 12122515 [TBL] [Abstract][Full Text] [Related]
39. Association of gout medications and risk of cataract: a population-based case-control study. Li YJ; Perng WT; Tseng KY; Wang YH; Wei JC QJM; 2019 Nov; 112(11):841-846. PubMed ID: 31286139 [TBL] [Abstract][Full Text] [Related]
40. Colchicine--what is its place in the management of acute gout? Winzenberg T; Zochling J Aust Fam Physician; 2007 Jul; 36(7):529-30. PubMed ID: 17619668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]